EMS provider Qisda has begun to tap the Southeast Asia market for medical devices, as K2 International Medical, in which Qisda holds a 37.56% stake, has announced the establishment of a subsidiary in Thailand to market hemodialyzers, hemodialysis services, and aesthetic medical products and services there, according to a Digitimes report.
Founded in 2006, K2 International distributes hemodialyzers, blood transfusion/purification and aesthetic medical products, and provides related services, and has served more than 100 hospitals and hemodialysis centers in Taiwan and China. Qisda, viewing that K2 International can complement its subsidiary BenQ Dialysis Technology's business, invested in it in September 2018.